Goldenwell Biotech GWLL
OTC GWLL
$0.69 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Goldenwell Biotech (GWLL) Current Deferred Revenue (2025 - 2026)

Updated

Goldenwell Biotech (GWLL) reported Current Deferred Revenue of $100,000 for Q2 2026, unchanged from $100,000 a year earlier and unchanged from the prior quarter.

Analysis

Goldenwell Biotech (GWLL) Current Deferred Revenue (2025 - 2026) Analysis & Trends

Dating back to Q2 2025, Goldenwell Biotech's Current Deferred Revenue record includes 5 quarters.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $100,000 (Q1 2026), $100,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn
10 Goldenwell Biotech 68.31 Mn 68.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
API Access

Goldenwell Biotech Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GWLL&period=max&api_key=YOUR_API_KEY